Table of Content



Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details of Primary Research
1.5 Information or Data Analysis
1.5.1 Platelet Rich Plasma (PRP) Market: segment revenue and growth analysis
1.5.2 sports medicine market: segment revenue and growth analysis
1.5.3 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment revenue and growth analysis
1.5.3.1 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment definition
1.5.3.1.1 Non-Healing Ulcers
1.5.3.1.1.1 Diabetic Ulcers
1.5.3.1.1.2 Pressure Ulcers
1.5.3.1.1.3 Pyoderma gangrenosum
1.5.3.1.1.4 Venous ulcers
1.5.4 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country-wise market estimation using the bottom-up approach
1.8 Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
Chapter 2 EXECUTIVE SUMMARY
2.1 Competition Milieu
2.2 Segment Outlook
2.3 Market Summary, 2019 (USD Million)
Chapter 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation
3.2 Parent Market Lineage
3.3 Market Dynamics
3.3.1 Market Drivers Analysis
3.3.1.1 Rise in the incidence of orthopedic disorders and sports injuries
3.3.1.2 Increasing number of cosmetic surgery procedures
3.3.1.3 Extending medical applications of platelet rich plasma
3.3.1.4 Increasing number of evidence-based studies for PRP-based wound healing
3.3.2 Market restraint Analysis
3.3.2.1 High costs associated with PRP products
3.3.3 Market opportunity Analysis
3.3.3.1 Increase in the breadth and use of PRP therapy across Medicare beneficiaries
3.4 Penetration & Growth Prospect Mapping, by Application, 2019
Chapter 4 BUSINESS ENVIRONMENT ANALYSIS
4.1 SWOT Analysis; by Factor (Political & Legal, Economic and Technological)
4.2 Porter’s Five Forces Analysis
Chapter 5 TYPE BUSINESS ANALYSIS
5.1 Platelet Rich Plasma (PRP) Market: Type Movement Analysis
5.2 Pure PRP
5.2.1 Pure PRP market estimates and forecast, 2016 - 2027 (USD Million)
5.3 Leukocyte Rich PRP
5.3.1 Leukocyte rich PRP market estimates and forecast, 2016 - 2027 (USD Million)
5.4 Others
5.4.1 PRP market estimates and forecast for others, 2016 - 2027 (USD Million)
Chapter 6 APPLICATION BUSINESS ANALYSIS
6.1 Platelet Rich Plasma (PRP) Market: Application Movement Analysis
6.2 Orthopedics
6.2.1 Platelet Rich Plasma (PRP) market estimates and forecast for Orthopedics, 2016 - 2027
6.3 Sports Medicine
6.3.1 Platelet Rich Plasma (PRP) market estimates and forecast for Sports medicine, 2016 - 2027
6.4 Cosmetic Surgery
6.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for cosmetic surgery, 2016 - 2027
6.5 Dermatology
6.5.1 coverage scenario: U.S. Centers for Medicare & Medicaid Services
6.5.2 Platelet Rich Plasma (PRP) Market estimates and forecast for dermatology, 2016 - 2027
6.5.3 Ulcer healing
6.5.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for ulcer healing, 2016 - 2027
6.5.3.2 Venous ulcers
6.5.3.2.1 Platelet Rich Plasma (PRP) Market estimates and forecast for venous ulcers, 2016 - 2027
6.5.3.3 Traumatic ulcers
6.5.3.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for traumatic ulcers, 2016 - 2027
6.5.3.4 Pyoderma gangrenosum ulcers
6.5.3.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for pyoderma gangrenosum ulcers, 2016 - 2027
6.5.3.5 Diabetic ulcers
6.5.3.5.1 Platelet Rich Plasma (PRP) Market estimates and forecast for diabetic ulcers, 2016 - 2027
6.5.3.6 Trophic ulcers
6.5.3.6.1 Platelet Rich Plasma (PRP) Market estimates and forecast for trophic ulcers, 2016 - 2027
6.5.3.7 Vasculitic ulcers
6.5.3.7.1 Platelet Rich Plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2016 - 2027
6.5.4 Others
6.5.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for others, 2016 - 2027
6.6 Ophthalmic Surgery
6.6.1 Platelet Rich Plasma (PRP) market estimates and forecast for Ophthalmic surgery, 2016 - 2027
6.7 Neurosurgery
6.7.1 Platelet Rich Plasma (PRP) market estimates and forecast for Neurosurgery, 2016 - 2027
6.8 General Surgery
6.8.1 Platelet Rich Plasma (PRP) market estimates and forecast for General surgery, 2016 - 2027
6.9 Others
6.9.1 Platelet Rich Plasma (PRP) market estimates and forecast for Others, 2016 - 2027
Chapter 7 END-USE BUSINESS ANALYSIS
7.1 Platelet Rich Plasma (PRP) Market: End-use Movement Analysis
7.2 Hospitals
7.2.1 Platelet Rich Plasma (PRP) market for hospitals, 2016 – 2027 (USD Million)
7.3 Clinics
7.3.1 Platelet Rich Plasma (PRP) market for clinics, 2016 – 2027 (USD Million)
7.4 Others
7.4.1 Platelet Rich Plasma (PRP) market for others, 2016 – 2027 (USD Million)
Chapter 8 REGIONAL BUSINESS ANALYSIS
8.1 Platelet Rich Plasma (PRP) Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Platelet rich plasma (PRP) market estimates and forecast, 2016 - 2027 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Platelet rich plasma (PRP) market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.2.2.2 U.S. Platelet rich plasma (PRP) market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.2.2.3 U.S. Platelet rich plasma (PRP) market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Platelet rich plasma (PRP) market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.2.3.2 Canada Platelet rich plasma (PRP) market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.2.3.3 Canada Platelet rich plasma (PRP) market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.3 Europe
8.3.1 Europe platelet rich plasma (PRP) market estimates and forecast, 2016 - 2027 (USD million)
8.3.2 Germany
8.3.2.1 Germany Platelet rich plasma (PRP) market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.3.2.2 Germany Platelet rich plasma (PRP) market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.3.2.3 Germany Platelet rich plasma (PRP) market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. Platelet rich plasma (PRP) market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.3.3.2 U.K. Platelet rich plasma (PRP) market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.3.3.3 U.K. Platelet rich plasma (PRP) market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific platelet rich plasma (PRP) market estimates and forecast, 2016 - 2027 (USD million)
8.4.2 Japan
8.4.2.1 Japan Platelet rich plasma (PRP) market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.4.2.2 Japan Platelet rich plasma (PRP) market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.4.2.3 Japan Platelet rich plasma (PRP) market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.4.3 CHINA
8.4.3.1 China Platelet rich plasma (PRP) market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.4.3.2 China Platelet rich plasma (PRP) market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.4.3.3 China Platelet rich plasma (PRP) market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.5 Latin America
8.5.1 Latin America platelet rich plasma (PRP) market estimates and forecast, 2016 - 2027 (USD million)
8.5.2 Brazil
8.5.2.1 Brazil Platelet rich plasma (PRP) market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.5.2.2 Brazil Platelet rich plasma (PRP) market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.5.2.3 Brazil Platelet rich plasma (PRP) market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.5.3 MEXICO
8.5.3.1 Mexico Platelet rich plasma (PRP) market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.5.3.2 Mexico Platelet rich plasma (PRP) market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.5.3.3 Mexico Platelet rich plasma (PRP) market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.6 Middle East & Africa
8.6.1 Middle East & Africa platelet rich plasma (PRP) market estimates and forecast, 2016 - 2027 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Platelet rich plasma (PRP) market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.6.2.2 South Africa Platelet rich plasma (PRP) market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.6.2.3 South Africa Platelet rich plasma (PRP) market estimates and forecast, by end use, 2016 - 2027 (USD Million)
Chapter 9 COMPANY PROFILE
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Johnson & Johnson
9.3.1.1 Company Overview
9.3.1.2 DePuy Synthes
9.3.1.2.1 Company Overview
9.3.1.3 Financial Performance
9.3.1.4 Product Benchmarking
9.3.1.5 Strategic Initiatives
9.3.2 Arthrex, Inc.
9.3.2.1 Company Overview
9.3.2.2 FINANCIAL PERFORMANCE
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 EmCyte Corporation
9.3.3.1 Company Overview
9.3.3.2 Product Benchmarking
9.3.3.3 Strategic Initiatives
9.3.4 DR. PRP AMERICA, LLC
9.3.4.1 Company Overview
9.3.4.2 Product Benchmarking
9.3.5 Juventix
9.3.5.1 Company Overview
9.3.5.2 FINANCIAL PERFORMANCE
9.3.5.3 Product Benchmarking
9.3.6 Terumo Corporation
9.3.6.1 Company Overview
9.3.6.2 TERUMO BCT, INC.
9.3.6.2.1 Company Overview
9.3.6.3 Financial Performance
9.3.6.4 Product Benchmarking
9.3.6.5 Strategic Initiatives
9.3.7 Zimmer Biomet
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 Stryker
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives_



List of Tables



Table 1 List of secondary sources
Table 2 Growth factors involved in stages of wound healing
Table 3 Growth factors involved in wound healing with their origin
Table 4 Use of PRP in wound management
Table 5 Randomized controlled trials: PRP-based wound healing
Table 6 Some of the prominent manufacturers operating in the pure PRP market
Table 7 Miscellaneous clinical applications for PRP
Table 8 Studies that have been approved by CMS for payment coverage with respect to PRP-based ulcer healing
Table 9 Comparative analysis of PRP efficacy on chronic ulcers, based on age group and ulcer type
Table 10 Some of the hospitals offering PRP treatment for different applications
Table 11 Some of the hospitals offering PRP treatment for different applications
Table 12 North America Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 13 North America Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 14 North America Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 15 North America Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 16 North America Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)
Table 17 U.S. Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 18 U.S. Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 19 U.S. Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 20 U.S. Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 21 U.S. Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)
Table 22 Canada Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 23 Canada Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 24 Canada Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 25 Canada Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 26 Canada Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)
Table 27 Europe Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 28 Europe Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 29 Europe Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 30 Europe Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 31 Europe Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)
Table 32 Germany Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 33 Germany Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 34 Germany Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 35 Germany Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 36 Germany Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)
Table 37 U.K. Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 38 U.K. Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 39 U.K. Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 40 U.K. Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 41 U.K. Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)
Table 42 Asia Pacific Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 43 Asia Pacific Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 44 Asia Pacific Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 45 Asia Pacific Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 46 North America Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)
Table 47 Some of the PRP service providers in Japan
Table 48 Japan Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 49 Japan Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 50 Japan Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 51 Japan Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 52 Japan Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)
Table 53 China Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 54 China Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 55 China Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 56 China Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 57 China Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)
Table 58 Latin America Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 59 Latin America Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 60 Latin America Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 61 Latin America Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 62 Latin America Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)
Table 63 Some of the hospitals & dental clinics for platelet-rich plasma therapy in Brazil
Table 64 Brazil Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 65 Brazil Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 66 Brazil Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 67 Brazil Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 68 Brazil Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)
Table 69 Mexico Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 70 Mexico Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 71 Mexico Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 72 Mexico Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 73 Mexico Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)
Table 74 Middle East & Africa Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 75 Middle East & Africa Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 76 Middle East & Africa Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 77 Middle East & Africa Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 78 Middle East & Africa Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)
Table 79 South Africa Platelet Rich Plasma (PRP) market estimates and forecast by type, 2016 - 2027 (USD Million)
Table 80 South Africa Platelet Rich Plasma (PRP) market estimates and forecast by application, 2016 - 2027 (USD Million)
Table 81 South Africa Platelet Rich Plasma (PRP) market estimates and forecast for dermatology by type, 2016 - 2027 (USD Million)
Table 82 South Africa Platelet Rich Plasma (PRP) market estimates and forecast for ulcer healing by type, 2016 - 2027 (USD Million)
Table 83 South Africa Platelet Rich Plasma (PRP) market estimates and forecast by end use, 2016 - 2027 (USD Million)